Search - tctmd.com

Displaying 21 - 32 of 32

Sort: Relevancy | Date

News Daily News

ASCVD and Cancer Diagnoses Pose Potentially Deadly Costs to Patients

Caitlin E. Cox

June 16, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for June Week 1

Todd Neale

June 01, 2021

News Conference News ACC 2021

Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients

Caitlin E. Cox

May 07, 2021

News Daily News

Longer Work Hours After MI Tied to Higher Risk of Recurrent Events

Caitlin E. Cox

April 01, 2021

News Daily News

Some Good News, Some Bad in Proposed 2021 CMS Reimbursement Changes

Yael L. Maxwell

August 07, 2020

News Daily News

Stress Cardiomyopathy Up in Ohio—but Not Directly Due to COVID-19

Yael L. Maxwell

July 13, 2020

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

News Daily News

Many US Cardiologists ‘On the Brink of Burnout’

Caitlin E. Cox

June 26, 2019

News Daily News

Financial Hardship From Medical Bills a ‘Growing Menace’ for ASCVD Patients

Michael O'Riordan

February 11, 2019

News Daily News

Skyrocketing Costs of CVD Will Be Amplified by Informal Caregiving: AHA

Shelley Wood

April 09, 2018

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Industry News

Philips and Corindus announce distribution agreement to sell Corindus' robotic-assisted interventional cardiology system in the United States

August 23, 2012

Advertisement

ASCVD and Cancer Diagnoses Pose Potentially Deadly Costs to Patients

COVID-19: TCTMD’s Daily Dispatch for June Week 1

Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients

Longer Work Hours After MI Tied to Higher Risk of Recurrent Events

Some Good News, Some Bad in Proposed 2021 CMS Reimbursement Changes

Stress Cardiomyopathy Up in Ohio—but Not Directly Due to COVID-19

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Many US Cardiologists ‘On the Brink of Burnout’

Financial Hardship From Medical Bills a ‘Growing Menace’ for ASCVD Patients

Skyrocketing Costs of CVD Will Be Amplified by Informal Caregiving: AHA

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

Philips and Corindus announce distribution agreement to sell Corindus' robotic-assisted interventional cardiology system in the United States

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content